Pancreatic polypeptide in obese children before and after weight loss

T Reinehr1, P J Enriori, K Harz

  • 1Vestische Hospital for Children and Adolescents Datteln, University of Witten/Herdecke, Datteln, Germany. T.Reinehr@kinderklinik-datteln.de

Insights

Pancreatic polypeptide (PP) levels are lower in obese children and normalize after weight loss. Low PP indicates overweight status, it does not cause it.

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Research
  • Obesity Studies

Background:

  • Pancreatic polypeptide (PP) role in childhood obesity and weight loss is understudied.
  • Obesity is associated with altered hormonal profiles, but PP's specific involvement remains unclear.

Purpose of the Study:

  • To investigate pancreatic polypeptide (PP) levels in obese children compared to lean children.
  • To examine the changes in PP concentrations during a 1-year weight loss intervention in obese children.

Main Methods:

  • Measured fasting PP, leptin, and insulin in 38 obese and 35 lean children.
  • Analyzed PP changes over one year in obese children undergoing weight loss treatment.
  • Used multiple linear regression to assess correlations between PP, BMI, leptin, and insulin.

Main Results:

  • Obese children exhibited significantly lower PP levels and higher leptin and insulin compared to lean peers.
  • PP levels negatively correlated with body mass index (BMI) in obese children.
  • Significant weight loss in a subset of children led to increased PP and decreased insulin and leptin levels.

Conclusions:

  • Decreased PP concentrations in obese children are linked to their overweight status, not other factors like age or leptin.
  • Weight loss intervention normalized reduced PP levels in obese children.
  • Low PP in obese children reflects their condition and is not a causative factor.
Abstract